Androgen replacement therapy

Androgen replacement therapy
Other namesTestosterone replacement therapy

Androgen replacement therapy (ART), often referred to as testosterone replacement therapy (TRT), is a form of hormone therapy in which androgens, often testosterone, are supplemented or replaced. It typically involves the administration of testosterone through injections, skin creams, patches, gels, pills, or subcutaneous pellets. ART is often prescribed to counter the effects of male hypogonadism.

ART is also prescribed to lessen the effects or delay the onset of normal male aging. However, this is controversial and is the subject of ongoing clinical trials.[1][2][3][4][5][6][7]

As men enter middle age they may notice changes caused by a relative decline in testosterone: fewer erections, fatigue, thinning skin, declining muscle mass and strength, and/or more body fat. Dissatisfaction with these changes causes some middle age men to seek ART. Androgen deficiencies in women have also, as of 2001, been recognized as a medical disorder that can be treated with ART.[8] As with men, symptoms associated with androgen deficiency are most prevalent with age, and androgen replacement therapy has been shown to help with symptoms of menopause.[9]

  1. ^ "Testosterone therapy: Key to male vitality?". Mayo Foundation for Medical Education and Research (MFMER). 2012.
  2. ^ Sood A, Hosseinpour A, Sood A, Avula S, Durrani J, Bhatia V, Gupta R (October 2023). "Cardiovascular Outcomes of Hypogonadal Men Receiving Testosterone Replacement Therapy: A Meta-analysis of Randomized Controlled Trials". Endocrine Practice. 30 (1): 2–10. doi:10.1016/j.eprac.2023.09.012. PMID 37797887. S2CID 263692728.
  3. ^ Valderrábano RJ, Pencina K, Storer TW, Reid KF, Kibel AS, Burnett AL, et al. (January 2023). "Testosterone replacement in prostate cancer survivors with testosterone deficiency: Study protocol of a randomized controlled trial". Andrology. 11 (1): 93–102. doi:10.1111/andr.13299. PMC 9771994. PMID 36181480.
  4. ^ Pencina KM, Travison TG, Artz AS, Lincoff AM, Nissen SE, Flevaris P, et al. (October 2023). "Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical Trial". JAMA Network Open. 6 (10): e2340030. doi:10.1001/jamanetworkopen.2023.40030. PMC 10611996. PMID 37889486.
  5. ^ Christensen LL, Poulsen HE, Andersen MS, Glintborg D (January 2024). "Whole-body oxidative stress reduction during testosterone therapy in aging men: A randomized placebo-controlled trial". Andrology. 12 (1): 115–122. doi:10.1111/andr.13458. PMID 37177884.
  6. ^ Diaz P, Reddy R, Blachman-Braun R, Zucker I, Dullea A, Gonzalez DC, et al. (April 2023). "Comparison of Intratesticular Testosterone between Men Receiving Nasal, Intramuscular, and Subcutaneous Pellet Testosterone Therapy: Evaluation of Data from Two Single-Center Randomized Clinical Trials". The World Journal of Men's Health. 41 (2): 390–395. doi:10.5534/wjmh.210261. PMC 10042650. PMID 35791295.
  7. ^ Corona G, Torres LO, Maggi M (March 2020). "Testosterone Therapy: What We Have Learned From Trials". The Journal of Sexual Medicine. 17 (3): 447–460. doi:10.1016/j.jsxm.2019.11.270. hdl:2158/1192573. PMID 31928918. S2CID 210191244.
  8. ^ Bachmann G, Bancroft J, Braunstein G, Burger H, Davis S, Dennerstein L, et al. (April 2002). "Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment". Fertility and Sterility. 77 (4): 660–665. doi:10.1016/S0015-0282(02)02969-2. PMID 11937111.
  9. ^ Sarrel PM (April 2002). "Androgen deficiency: menopause and estrogen-related factors". Fertility and Sterility. 77 (Suppl 4): S63–S67. doi:10.1016/S0015-0282(02)02967-9. PMID 12007905.

© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search